1. Home
  2. EYEN vs HAO Comparison

EYEN vs HAO Comparison

Compare EYEN & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • HAO
  • Stock Information
  • Founded
  • EYEN 2014
  • HAO 2018
  • Country
  • EYEN United States
  • HAO China
  • Employees
  • EYEN N/A
  • HAO N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • HAO
  • Sector
  • EYEN Health Care
  • HAO
  • Exchange
  • EYEN Nasdaq
  • HAO NYSE
  • Market Cap
  • EYEN 9.2M
  • HAO 7.4M
  • IPO Year
  • EYEN 2018
  • HAO 2024
  • Fundamental
  • Price
  • EYEN $0.08
  • HAO $0.12
  • Analyst Decision
  • EYEN Hold
  • HAO
  • Analyst Count
  • EYEN 4
  • HAO 0
  • Target Price
  • EYEN $2.00
  • HAO N/A
  • AVG Volume (30 Days)
  • EYEN 19.0M
  • HAO 7.4M
  • Earning Date
  • EYEN 11-12-2024
  • HAO 10-29-2024
  • Dividend Yield
  • EYEN N/A
  • HAO N/A
  • EPS Growth
  • EYEN N/A
  • HAO 20.20
  • EPS
  • EYEN N/A
  • HAO 0.04
  • Revenue
  • EYEN $31,832.00
  • HAO $48,519,836.00
  • Revenue This Year
  • EYEN $23,413.60
  • HAO N/A
  • Revenue Next Year
  • EYEN $400.98
  • HAO N/A
  • P/E Ratio
  • EYEN N/A
  • HAO $3.23
  • Revenue Growth
  • EYEN 2557.10
  • HAO 71.88
  • 52 Week Low
  • EYEN $0.08
  • HAO $0.12
  • 52 Week High
  • EYEN $2.57
  • HAO $10.60
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 27.49
  • HAO 36.85
  • Support Level
  • EYEN $0.08
  • HAO $0.12
  • Resistance Level
  • EYEN $0.09
  • HAO $0.14
  • Average True Range (ATR)
  • EYEN 0.01
  • HAO 0.02
  • MACD
  • EYEN 0.01
  • HAO 0.01
  • Stochastic Oscillator
  • EYEN 13.08
  • HAO 40.79

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving leading customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: